Description: Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Home Page: www.sequent.in
Dosti Pinnacle
Mumbai,
400604
India
Phone:
91 22 4111 4777
Officers
Name | Title |
---|---|
Mr. Rajaram Narayanan | MD, CEO & Director |
Mr. Saurav Bhala | Chief Financial Officer |
Mr. Phillip Trott | Secretary, Compliance Off., Assoc. VP, Head of Legal, Secretarial & Compliance and Chief Risk Off. |
Mr. Ramesh Kumar Pillai | Corporate Vice President of Ra Qa and Technical Services |
Mr. Ravi Nair | Executive Vice President of Human Resources & Administration |
Mr. Abhishek Singhal | Head of Investor Relations |
Mr. Vedprakash Ragate | Executive Director |
Mr. Prasad Lad | Vice President of HR & Administration |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 33.3333 |
---|---|
Trailing PE: | 294.697 |
Price-to-Book MRQ: | 7.223 |
Price-to-Sales TTM: | 3.459 |
IPO Date: | |
Fiscal Year End: | March |
Full Time Employees: | 1195 |